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Calcium bioaccessibility and uptake by human
intestinal like cells following in vitro digestion of
casein phosphopeptide–calcium aggregates
Silvia Perego,†a Elena Del Favero,b Paola De Luca,a Fabrizio Dal Piaz,c Amelia Fiorilli,a
Laura Cantu’b and Anita Ferraretto*a
Casein phosphopeptides (CPPs), derived by casein proteolysis, can bind calcium ions and keep them in
solution. In vitro studies have demonstrated CPP-induced cell calcium uptake, depending on the for-
mation of (CPP + calcium) complexes and on the degree of diﬀerentiation of the intestinal cells. With the
present study, we address the persistence of the complexes and of the CPP-induced calcium uptake in
intestinal like cells after the digestion process, thus examining their eligibility to serve as nutraceuticals.
A calcium-preloaded CPP preparation of commercial origin (Ca–CPPs) was subjected to in vitro digestion.
The evolution of the supramolecular structure of the Ca–CPP complexes was studied using laser-light
and X-ray scattering. The bioactivity of the pre- and post-digestion Ca–CPPs was determined in diﬀeren-
tiated Caco2 and HT-29 cells by video imaging experiments using Fura-2. We found that Ca–CPP aggre-
gates keep a complex supramolecular organization upon digestion, despite getting smaller in size and
increasing internal calcium dispersion. Concomitantly and most interestingly, digested Ca–CPPs clearly
enhance the uptake of calcium ions, especially in Caco2 cells. In contrast, digestion depletes the ability of
post-loaded decalciﬁed-CPPs (Ca–dekCPPs), with a weaker internal structure, to induce calcium uptake.
The enhanced bioactivity reached upon digestion strongly suggests a recognized role of Ca–CPPs, in the
form used here, as nutraceuticals.
1. Introduction
The retention or acquisition of a specific biological activity
after the digestion process is a prerequisite to define a “func-
tional food”. This essential property is mostly due to the pres-
ence of specific molecules, identified or not, contained in the
food and released mainly by the digestion process. Milk pro-
teins represent a good example of this possibility, since they
constitute a source of many biologically active peptides exert-
ing their bioactivity at diﬀerent physiological levels.1,2 There-
fore, dairy products can be fully considered as functional
foods and the bioactive molecules present inside as
nutraceuticals.
Numerous studies have investigated the persistence of
milk-derived peptides both after the in vitro digestion3–5 and
in vivo in the intestine of humans.6,7 The next step, therefore,
is to demonstrate that, although eventually modified by diges-
tion, these peptides and especially their bioactive aggregated
complexes can retain or even acquire their biological capacity.
Due to the diverse chemico-physical structure and function
displayed by the diﬀerent milk-derived peptides, it is likely
that both their resistance to proteolysis and their bioactivity
could be non-uniform, according to the experimental and/or
physiological conditions.5
In the present paper we deal with the casein phospho-
peptides (CPPs), derived by casein proteolysis, which have the
ability to bind calcium ions, include them in complexes and
keep them in solution.8
In vitro studies, using human intestinal cell models, have
demonstrated the involvement of CPPs in cell calcium uptake,
depending on the formation of (CPP + calcium) aggregates9
and on the degree of diﬀerentiation of the intestinal cells.10 It
is noteworthy that the calcium uptake triggered by CPPs in the
two intestinal human in vitro cell models used, namely, diﬀer-
entiated Caco2 and HT-29 cells, involves two diﬀerent mecha-
nisms at the membrane level. In HT-29 cells, calcium uptake
occurs via the depolarizing L-type calcium channels. Instead,
in Caco2 cells, it involves the transient receptor potential
cation of the vanilloid subfamily V member 6, TRPV6 channel,
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also designated as calcium transporter-1 or CaT1.11,12 Both
channels are recognized to exert an active role in intestinal
calcium absorption, although with important diﬀerences
regarding vitamin D regulation, the intestinal tract of interest,
and the condition of activation/inactivation (by depolarization
or hyperpolarization).11
The interaction of CPPs with these channels, promoting
calcium uptake, also aﬀects cell proliferation and apoptosis,
through the role exerted by calcium ions themselves in these
processes, a property which could have potential implications
to the tumour/normal cell phenotype.13–15 Also on this basis,
it is of paramount interest to prove that CPPs can behave as
nutraceuticals, keeping their features and bioactivity after their
localization in the intestine.
It is known that the digestion of casein micelles, the form
with which casein is bound to calcium ions in milk, gives rise
to complexes containing calcium phosphate and CPPs, namely
αs1-CPP and β-CPP, displaying diﬀerent binding properties for
calcium and phosphate, as compared to casein.16
The present study is devoted to assessing the eligibility of
CPPs to serve as nutraceuticals. To address this issue, the
bioaccessibility of the (CPP + calcium) complexes was analysed
in cultures of intestinal human cells. The bioavailability of the
same calcium–CPP complexes has been studied in the past
and positively established by means of experiments in
humans17,18 identifying a positive eﬀect on calcium and zinc
absorption, together with a recognized mineral bioavailability
in rat pups.19 Calcium–CPP complexes have shown up to be
bioactive also at the bone level. In fact, the ingestion of
calcium–CPP complexes inhibited the bone loss in aged ovari-
ectomized rats20 and supplementation with CPPs of diﬀerent
origins increased calcification of the diaphyseal area of
explanted rat bone rudiments in vitro.21 Another recognized
positive eﬀect of CPPs is at the dental level, with an anticario-
genic role due to the increase of the plaque level of calcium
phosphate.22,23
The present study is therefore conceived to verify the per-
sistence, along and after a simulated digestion, (i) of the CPP-
calcium aggregates (the bioactive form) and (ii) of their ability
to induce the calcium uptake by the cells, a feature that was
demonstrated in a previous study.24 We underline that we
focus on calcium uptake connected to ion transport, by select-
ing suitable, short, observation times. Any concern to the
peptide transport is outside the scope of our study. Great care
was taken to ensure that all the measurements, both structural
(i) and biological (ii), were performed under the same experi-
mental conditions (the peptide/calcium molar ratio and the
absence of inorganic phosphate in the solution) for punctual
comparison. All the experiments were performed on a CPP
preparation, characterized in a previous study, consisting of a
mixture of peptides (mainly from the N-terminus of beta
casein, but also from alpha s1 casein) already calcium-contain-
ing (6.6% w/w), roughly corresponding to 1.5 calcium ions per
organic phosphate (3.2% w/w) and particularly resistant to
variations in the (possibly random) environmental calcium
ion concentration,24 hereafter Ca–CPPs. The same experiments
were also carried out using complexes obtained by post-
loading calcium to the decalcified form of the same CPPs
(hereafter Ca–dekCPPs). In fact, dekCPP has been proved to be
very eﬃcient in complexing all of the available calcium ions,24
thus it may be suitable as a high-performing nutraceutical,
considering that after a meal CPPs come in contact with a
huge amount of calcium.25
2. Materials and methods
2.1. Materials and reagents
Cell culture media, L-glutamine, antibiotic–antimycotic solu-
tion, sodium pyruvate, trypsin-EDTA solution, EGTA and all
other reagents, unless otherwise specified, were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Foetal bovine serum
(FBS) was from EuroClone Ltd (West Yorkshire, UK). Fura-2
acetoxymethyl ester (Fura-2/AM) was from Calbiochem (La
Jolla, CA, USA).
2.2. Casein phosphopeptides (CPPs)
The CPP preparation (Peptigen®110) used here was kindly pro-
vided by MD Foods Ingredients Amba (Videbaek, Denmark)
and represents a purified tryptic casein hydrolysate containing
a very high level of CPPs. This preparation was previously
studied for it concerns product quality parameters such as
calcium content, CPP and protein content, Ser/P ratio26 and
the ability to induce calcium uptake in intestinal cells.24 The
MALDI-TOF/MS analysis24 identified two main components,
an N-terminal tryptic peptide 1–25, obtained from beta casein,
bearing four phosphate groups, and a 62–79 peptide obtained
from alpha s1 casein, with three phosphate groups. Based on
the size distribution given by the MS spectra, the average mole-
cular weight was assumed to be 2500.24 Its composition from
the manufacturing data sheet, which is in accordance with
data published,26 is the following: 95% CPP content; 6.6%
calcium content; 3.2% phosphorus content; N/P ratio: 7.8 mol
mol−1; Ser/P ratio: 0.97 mol mol−1. CPP solutions used in all
the experiments were prepared at 1280 µM peptide concen-
tration, corresponding to the maximum activity in inducing
the intracellular calcium rise.9,10,24 As a main feature, these
CPPs, hereafter Ca–CPPs, contain calcium at the origin, in the
stock powder preparation. As determined previously,24 a frac-
tion of the pre-loaded calcium is stably associated with Ca–
CPP complexes, an amount nicely independent of the extra
calcium present in the solution.
An aliquot of Ca–CPPs was decalcified, by the chelating ion
exchange resin Chelex100 (Bio-Rad Laboratories, Hercules, CA,
USA), according to the procedure already described.24 This
second CPP preparation was named dekCPP, in opposition to
its parent Ca–CPP, and Ca–dekCPP after dissolution in a
calcium-containing solvent. In order to prepare the Ca–
dekCPP complexes, calcium was added with the solvent used
to solubilize the dekCPP powder.
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2.3. In vitro digestion of Ca–CPPs and Ca–dekCPP
Enzymes and bile salts were purchased from Sigma-Aldrich
(St. Louis, MO, USA). 40 mg of porcine pepsin (EC 3.4.23.1,
catalog no. P-7000) was suspended in 1 mL of 0.1 N HCl;
20 mg of pancreatin (catalog no. P-1750) and 120 mg bile
extract (catalog no. B-8631) were dissolved in 10 mL of 0.1 M
NaHCO3.
3 mL of double distilled water were added to 500 mg of Ca–
CPPs (50× concentrated, with respect to the final concen-
tration) and the pH was adjusted to 2 with 5 M HCl. The same
procedure was applied to dekCPPs, but calcium was also
added, as CaCl2, in order to reproduce the amount embedded
in Ca–CPP complexes (two calcium ions per peptide chain).
The two samples were then subjected in parallel to simulated
digestion, as follows. 5 mg of freshly prepared pepsin solution
were added, and the samples were incubated in a shaking
water bath at 37 °C for 90 min. The gastric digests were then
kept in ice for 10 minutes to stop the pepsin digestion. Prior
to the intestinal digestion step, the pH of the gastric digests
was raised to 6 by dropwise addition of 1 M NaHCO3. Succes-
sively, 8.75 mg of the pancreatin–bile extract mixture were
added and the incubation was continued for an additional 2 h.
After that, the samples were put in an ice bath for 10 min to
stop the intestinal digestion. The pH was adjusted to 7.2 by
dropwise addition of 0.5 M NaOH. The intestinal digests were
heated for 4 min at 100 °C to inhibit proteases and then
immersed in an ice bath to cool. Then, aliquots of 1 mL of the
samples were transferred to centrifuge tubes polyallomer®
(Beckman Coulter, Brea, CA, USA) and centrifuged at 12 000g
for 30 min at 4 °C (TL-100 Ultracentrifuge, Beckman Coulter).
The supernatants were transferred and pooled at −20 °C.
Finally, water was added to adjust the osmolarity to 300 ±
20 mOsm kg−1 (cryoscopic osmometer Osmomat 030, Gonotec
GmbH, Berlin, Germany).27,28
Both the initial and the digested final samples of both
CPPs were subjected to the Lowry protein assay,29 showing a
protein recovery of 82%.
2.4. LC/MS/MS analysis
Peptides were analyzed by LC/MS/MS using an Orbitrap XL
instrument (Thermo Fisher, Waltham, MA, USA) equipped
with a nano-ESI source coupled with a nano-ACQUITY capillary
UPLC (Waters, Milano, Italy): peptide separation was per-
formed on a capillary BEH C18 column (0.075 mm × 100 mm,
1.7 μm, Waters) using aqueous 0.1% formic acid (A) and
CH3CN containing 0.1% formic acid (B) as mobile phases. Pep-
tides were eluted by means of a linear gradient from 5% to
50% of B in 45 min and a 300 nL min−1 flow rate. Mass
spectra were acquired over an m/z range of 400–1800; the ten
most intense doubly-, triply- or quadruply-charged ions
detected in each spectrum underwent CID fragmentation
(dependent scan acquisition mode) and MS/MS spectra were
acquired over an m/z range of 50–2000. MS and MS/MS data
were used by Mascot (Matrix Science, London, UK) to interro-
gate the Swiss-Prot protein database. Settings were as follows:
taxonomy, other mammalia; enzyme, no cleave; mass accuracy
window for parent ions, 10 ppm; mass accuracy window for
fragment ions, 50 millimass units; no fixed modification; vari-
able modifications, phosphorylation of serine, threonine and
tyrosine, oxidation of methionine.
2.5. Laser light scattering
Aliquots of CPPs, dissolved in pure water as concentrated
stocks, were diluted in phosphate-free KRH with calcium at
concentrations matching those used to monitor the CPP bio-
logical eﬀect. The laser light scattering apparatus has been
designed in our laboratories (Department of Medical Biotech-
nology and Translational Medicine, University of Milan) to be
quite sensitive, thanks to four optical channels. It includes a
diode laser (λ = 532 nm) and a temperature controlled cell.
Both independent static (SLS) and dynamic (QELS) laser light
scattering measurements were performed on each sample at
room temperature. Dynamic measurements, through the corre-
lation function of the scattered intensity, yield the transla-
tional diﬀusion coeﬃcients of particles in solution and then,
via the Stokes–Einstein relation, their average hydrodynamic
diameter. By parallel static measurements of the average scat-
tered intensity, information on the mass of particles in solu-
tion were obtained.
2.6. Small angle X-ray scattering (SAXS)
SAXS measurements were performed at the ID02 high-brilli-
ance beamline at the ESRF (Grenoble, France), with a beam
cross section of 0.3 mm × 0.8 mm and a wavelength of 0.1 nm,
in the region of momentum transfer, q = (π/λ)sin(θ/2),
0.017 nm−1 ≤ q ≤ 4.65 nm−1, where θ is the scattering angle.
All measurements were performed at room temperature with a
very short exposure time, 0.1 s, in order to avoid any radiation
damage. Samples were put in plastic capillaries (KI-beam,
ENKI, Concesio, Italy) mounted horizontally onto a six-places
sample holder, allowing for nearly contemporary measure-
ments on sample and reference cells. The measured SAXS pro-
files report the scattered radiation intensity I(q) as a function
of the momentum transfer, q. Several spectra relative to the
empty cells and the solvent were taken, carefully compared
and subtracted to each sample spectrum. A SAXS analysis was
carried out to assess the structure of the particles in solution
on a more local, internal, scale with respect to laser light scat-
tering analysis. The experimental I(q) profile was then fitted
with the internal form factor (PInt) characteristic of structures
obtained by random condensation of functional monomers, in
which the resulting statistic of the subchains is Gaussian. For
equal reaction probability of the functional groups: PInt =
1/(1 + 〈Rg
2〉q2/3),30 where 〈Rg
2〉 is the average radius of gyration
squared of the subchain, proportional to the correlation
length within the entanglement network. We also tested the
model developed for the internal structure of casein micelles,
which consists of calcium phosphate nanoparticles reticulated
in the peptide matrix.31 This model is not suitable for the
internal structure of CPP aggregates and has been discarded.
Paper Food & Function
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2.7. Cell culture
The human colon adenocarcinoma cell lines Caco2 (BS TCL
87) and HT-29 (BS TCL 132) were supplied by Istituto Zooprofi-
lattico Sperimentale di Brescia (Brescia, Italy).
Caco2 cells were cultured in 75 cm2 plastic flasks (VWR
International PBI, Milan, Italy) in EMEM (Minimum Essential
Medium Eagle’s) growth medium supplemented with 15%
heat-inactivated foetal bovine serum (FBS), 1 mM sodium pyru-
vate, 2 mM L-glutamine, 0.1 mg L−1 streptomycin, 1 × 105 U
L−1 penicillin, and 0.25 mg L−1 amphotericin-B. The diﬀeren-
tiation of Caco2 cells was achieved according to the well-estab-
lished procedure32 consisting of successive sub-cultivations
without reaching the post-confluent stage.
HT-29 cells were grown (75 cm2 plastic flasks, VWR Inter-
national PBI) in RPMI 1640 medium (Roswell Park Memorial
Institute), supplemented with 10% heat-inactivated foetal
bovine serum, 2 mM L-glutamine, 0.1 mg L−1 streptomycin, 1 ×
105 U L−1 penicillin, and 0.25 mg L−1 amphotericin-B, obtain-
ing a population of diﬀerentiated and polarized cells, although
with a high degree of heterogeneity.33
All cell cultures, kept at 37 °C under a 5% CO2–95% air
atmosphere, were periodically checked for the presence of
mycoplasma and were found to be free of contamination.
2.8. Measurement of cytoplasmic calcium content, [Ca2+]i, at
the single-cell level
Cytoplasmic calcium, [Ca2+]i, was measured in cells seeded on
glass coverslips (∅ = 24 mm) and loaded with 2.5 µM Fura-2/
AM and 2.5 µM Pluronic F-127, in phosphate-free Krebs Ringer
HEPES solution (KRH, 140.0 mM NaCl, 5.0 mM KCl, 2 mM
CaCl2, 0.55 mM MgCl2, 6.0 mM glucose and 10.0 mM HEPES,
pH 7.4) as previously described.9–11,34 Fluorescence determi-
nation was performed with a microscope (TE 200, Nikon,
Tokyo, Japan) connected to a CCD intensified camera
(Extended Isis, Photonic Science, Millham, UK) and to a ther-
mostatted (TC-202 A, Medical System Corporation, Harvard
Apparatus, Holliston, MA, USA) perfusion chamber (PDMI-2,
the same commercial source). The amount of intracellular free
calcium, [Ca2+]i, within every single cell, was calculated using a
fluorescence image acquisition and data analysis system
(Applied Imaging, High Speed Dynamic Video Imaging
Systems, Quanticell 700, Sunderland, UK) from the 340/
380 nm images, using a calibration performed with external
standards of calcium and Fura-2, according to the equation
reported in ref. 35. Fig. 5 and 6 show one representative experi-
ment from 6–8 replicates (the number of technical replicates)
for each of the following samples: Ca–CPPs, digested Ca–CPPs,
Ca–dekCPPs and digested Ca–dekCPPs. In each experiment,
70–90 cells were analysed (biological replicates). Fig. S1 and
S2 in the ESI† show the average behaviour plus the standard
deviation from all the replicates. The average values for all the
technical replicates for each sample were reported as: (i)
percent of cells responding to CPP administration with an
increment in the intracellular calcium concentration; (ii) the
mean single-cell [Ca2+]i rise, namely, the diﬀerence between
the maximum and the basal values of [Ca2+]i for each cell, aver-
aged over the analysed cell population (Δ[Ca2+]i), composed of
400 Caco2 cells and 500 HT-29 cells; (iii) the total [Ca2+]i rise
(tot[Ca2+]i), obtained by multiplying the percent of responsive
cells by the mean single [Ca2+]i rise (Δ[Ca2+]i).
2.9. Statistical analysis of cell population
To determine statistically significant diﬀerences (p < 0.005 or
p < 0.01), the results obtained were analyzed by Student’s
t-test, independent two population test and χ2 test.
3. Results
The results obtained by the two parallel sets of experiments,
structural and biological, are reported separately in the follow-
ing, for clearer description, and then merged in the
discussion.
3.1. Structural results
3.1.1. LC-ESI-MS/MS results. In Table 1 the main mole-
cular mass peptides derived from the in vitro digestion of CPPs
are listed, as identified by their molecular mass. A number of
short peptides from beta and alpha s1 casein were detected,
most of which comprise one or more phosphorylated serines.
In particular, the peptides from beta casein are more abundant
than those of alpha s1 casein and they are constituted by a
smaller number of amino acids. Peptides from beta casein
derived mainly from the N-terminus portion as 1–25 or 33–55
polypeptide chain, while those from alpha casein derived from
the alpha 110–119 portion.
3.1.2. Laser light scattering results. Laser light scattering
measurements were performed to characterize the Ca–CPP and
Ca–dekCPP supramolecular complexes on the colloidal length-
scale and to follow their possible disaggregation upon diges-
tion. These aggregated structures are formed due to the inter-
action between negatively charged phosphorylated serines and
positive divalent calcium ions. In the present work, before
digestion (pH 7.4), the fraction of calcium embedded within
the aggregates is the same for both Ca–CPPs and Ca–dekCPPs,
namely ∼2 Ca/CPPs mole/mole, as recalled before. The pres-
ence of aggregated structures is essential for the bioactivity of
CPPs, as the fraction of calcium internalized by cells is actually
the CPP-complexed calcium.9,24 Before digestion, both CPPs
form aggregates with a similar average hydrodynamic radius
and quite a high polydispersity (140 ± 25 nm).
In order to follow the evolution of the supramolecular com-
plexes during the digestion process, we designed two experi-
ments. In the first experiment, we simply changed the pH of
the solution, from pH 7.4 down to pH 2 and back to neutral
pH. The average overall size of the complexes was determined
at the diﬀerent stages of the experiment. Although obtained in
the absence of digestive enzymes, these results may be funda-
mental to understand the behaviour of the supramolecular
complexes. In fact, CPPs, produced by tryptic hydrolysis of
sodium caseinate24 in the commercial product used here, are
Food & Function Paper
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similar to those produced by the enzymes operating along the
physiological digestive process. In the second experiment, we
followed the in vitro digestion protocol described in the
Materials and methods section, adding enzymes to the CPPs at
the appropriate pH values. Laser light scattering experiments
were performed on CPP solutions at the beginning, after acidi-
fication and/or pepsin addition, and at the end of the process.
The measured size distribution of the CPP complexes at
diﬀerent pH values, characteristic of each digestion step, for
both Ca–CPP (left side) and Ca–dekCPP (right side), is reported
in Fig. 1. The complexes are classified into three size
ranges (tens, hundreds and thousands of nm) and their rela-
tive importance is reported as relative scattered intensity.
Results in Fig. 1 clearly show that, as compared to the initial
stage (left bar in both groups), upon acidification the distri-
bution shifts to smaller size (tens of nm) for both systems
(central bar). As the pH is raised again, large aggregates
quickly reform (right bar). This general behaviour is displayed
by both systems.
Results relative to the experiment performed on CPP solu-
tions in the presence of diﬀerent enzymes, pepsin and pan-
creatin at diﬀerent pH, showed that the evolution of the overall
size of the complexes is qualitatively similar. A detailed assess-
ment of the size distribution of the CPP complexes, in this
case, is prevented by the interference of the scattered intensity
coming from the enzyme preparations themselves.
3.1.2. SAXS results. The internal structure of CPP com-
plexes and its evolution during the digestion process were
assessed by SAXS measurements. Spectra are reported in
Fig. 2, for both Ca–CPPs and Ca–dekCPPs, at the three stages
of simulated digestion, as before. The X-ray scattered-intensity
profile, in the high-q region, corresponding to short distances
within the aggregate (local structure), is similar for all spectra,
showing a q−2 decay of I(q). This behaviour is characteristic of
non-globular objects with fractal or entangled chain-like con-
formation. In the low-q region, corresponding to longer dis-
tances, the intensity profiles display a slight increase, relative
to the overall structure of the aggregates, typically assessed by
light scattering, as above. Those results on the structure of
CPP complexes, although apparently not so far from the ones
obtained on casein micelles,31,36–40 nonetheless unravel inter-
esting diﬀerences regarding the sites of calcium inclusion,
connected to the absence, in Ca–CPPs, of excess phosphate, as
we will point out in the Discussion section.
Table 1 LC-ESI-MS/MS based identiﬁcation of the main molecular mass peptides from the enzymatically digested CPP sample
Parent protein Position Observed Mr (expt) Mr (calc.) ppm Peptide
Beta casein 1–6 394.7117 787.4078 787.4075 0.65 A.RELEEL.N
Beta casein 1–11 642.8264 1283.6362 1283.6357 0.98 A.RELEELNVPGE.I
Beta casein 1–16 953.4642 1904.9138 1904.9132 0.34 A.RELEELNVPGEIVESL.S + Phospho (S)
Beta casein 4–11 443.7116 885.4086 885.408 0.78 L.EELNVPGE.I
Beta casein 6–14 485.2662 968.5178 968.5179 −0.0052 E.LNVPGEIVE.S
Beta casein 6–16 625.3076 1248.6006 1248.6003 0.31 E.LNVPGEIVESL.S + Phospho (S)
Beta casein 7–16 568.7657 1135.5168 1135.5162 0.57 L.NVPGEIVESL.S + Phospho (S)
Beta casein 30–44 974.3999 1946.7792 1946.7782 1.61 K.IEKFQSEEQQQTEDE.L + Phospho (S)
Beta casein 33–45 845.8281 1689.6416 1689.6407 0.57 K.FQSEEQQQTEDEL.Q + Phospho (S)
Beta casein 33–48 1031.4194 2060.8242 2060.8212 1.5 K.FQSEEQQQTEDELQDK.I + Phospho (S)
Alpha s1 casein 41–70 971.2587 3881.0457 3881.0514 −0.5 L.SKDIGSESTEDQAMEDIKQMEAESISSSEE.I + 2 Oxidation (M);
7 Phospho (S)
Alpha s1 casein 43–58 972.3469 1942.6792 1942.6792 0.033 K.DIGSESTEDQAMEDIK.Q + oxidation (M); 2 Phospho (S)
Alpha s1 casein 109–118 590.7621 1179.5066 1179.506 1.08 Q.LEIVPNSAEE.R + Phospho (S)
Alpha s1 casein 110–118 534.2196 1066.4226 1066.422 0.53 L.EIVPNSAEE.R + Phospho (S)
Fig. 1 Size distribution of Ca–CPP (left side) and Ca–dekCPP (right
side) complexes at diﬀerent pH values, characteristic of each digestion
step: initial, pH 2, pH 6. The complexes are classiﬁed as belonging to
three size-ranges (tens, hundreds and thousands of nm) and their rela-
tive importance is expressed as relative scattered intensity (%).
Fig. 2 Ca–CPP (left) and Ca–dekCPP (right) SAXS spectra at diﬀerent
digestion steps: the initial state (blue), after gastric phase (cyan), and
after intestinal phase (red). A shoulder is visible in the intensity proﬁle
corresponding to the initial state of Ca–CPPs. In the other spectra, the
intensity proﬁles at low q display a slight increase, a sign of the aggre-
gates’ overall structure.
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Analysis of the scattered intensity has been performed fol-
lowing the model described in the Materials and methods
section. We also tested and rejected the model developed for
the internal structure of casein micelles, characterized by
calcium phosphate nanoparticles reticulated in the peptide
matrix.31 The internal structure of the (CPP + calcium)
complex was modelled as a collection of randomly condensing
monomers. These monomers, the peptide chains, entangle
thanks to the interaction of negatively-charged phosphory-
lated-serine residues and divalent positive calcium ions. On a
local length scale, small compared to the mesh size of the
entangled network, we could observe the structure of the indi-
vidual flexible subchains. Results on the average radius of gyra-
tion of the subchains for the Ca–CPPs and Ca–dekCPPs are
reported in Fig. 3 at diﬀerent digestion steps: the initial con-
dition (1), after acidification and pepsin action (2), and after
pancreatin action (3).
In addition, in the SAXS intensity profile relative to the Ca–
CPP sample in its initial state, a shoulder is clearly visible, a
signature of a structure factor. The experimental structure
factor, reported in Fig. 4, shows a peak (qpeak = 0.29 nm
−1) con-
firming the presence of inter-chain interactions between pep-
tides that, in the entangled phase, assume a preferential
distance (d = 22 nm). Interestingly, after acidification and
pepsin addition, this structure peak disappears, indicating
that the internal structure of the Ca–CPP complexes becomes
more flexible and irregular.
3.2. Biological results
The changes in the intracellular calcium concentration, [Ca2+]i,
induced by both Ca–CPPs and Ca–dekCPPs and their digested
counterparts, all containing the same amount of calcium, were
evaluated and analysed in diﬀerentiated Caco2 and HT-29
cells. An example of the profiles of the single cell responsive-
ness to CPPs is reported in Fig. 5 and 6, while the average cell
response plus the standard deviation is reported in Fig. S7 and
S8 in the ESI.† The eﬀects of the diﬀerent administrations,
expressed as percent of the responsive cells, together with the
increment in the cytoplasmic calcium concentration (Δ[Ca2+]i),
for any single cell and for the whole cell population (tot
[Ca2+]i), are reported in Tables 2 and 3.
In Caco2 cells (see Fig. 5 and Table 2) the administration of
the digested Ca–CPP instead of its undigested counterpart pro-
duces calcium uptake in a higher fraction of cells (70% vs.
15%), as well as a higher increase in the intracellular calcium
concentration (Δ[Ca2+]i, 45 ± 10 nM vs. 27 ± 9 nM). Between
the undigested forms, Ca–dekCPP is more eﬀective than Ca–
CPP, both as a fraction of responding cells (26% vs. 15%) and
as a [Ca2+]i increase (40 ± 20 nM vs. 27 ± 9 nM). Digestion of
Ca–dekCPP does not significantly alter the single-cell incre-
ment in calcium uptake (Δ[Ca2+]i), despite occurring in a
smaller population of cells (18% vs. 26%). Interestingly, when
digested complexes are supplied, the recovery of the intracellu-
lar calcium basal level occurs on much longer time scales,
roughly fourfold. This feature is common to both Ca–CPPs
and Ca–dekCPPs.
In HT-29 cells (see Fig. 6 and Table 3), again, the adminis-
tration of the digested Ca–CPP produces a cellular response
significantly higher than that produced by its undigested
counterpart, both as a fraction of responsive cells (89% vs.
70%) and in the intracellular calcium increase (115 ± 19 nM
vs. 76 ± 28 nM). Administering the undigested Ca–dekCPP, as
reported previously,24 induced calcium uptake in a higher
number of cells with respect to Ca–CPP (93% vs. 70%), with an
overall extent reached by Ca–CPPs only after digestion. Rever-
sely, digestion reduces the eﬀectiveness of Ca–dekCPPs to
promote single-cell calcium uptake (from 113 ± 59 to 79 ± 14
nM), although acting on the same fraction of cells (96% vs.
93%). The kinetic profiles of the intracellular calcium concen-
tration show the same features observed in Caco2 cells, i.e., a
slower recovery of the basal level and a higher heterogeneity in
the cell behaviour in the case of digested CPPs.
As a whole, these data indicate that digestion of Ca–CPPs
results in an increment both in the number of cells respond-
Fig. 3 Ca–CPP (blue) and Ca–dekCPP (magenta) local structures.
Radius of gyration of the subchains within the entanglement network at
diﬀerent digestion steps: (1) initial, (2) after acidiﬁcation and pepsin
action, and (3) after pancreatin action at pH 6.
Fig. 4 Experimental structure factor S(q) for Ca–CPPs under the initial
conditions. The peak at q = 0.29 nm−1 indicates the presence of inter-
chain interactions that assume a preferential distance in the entangled
phase. The characteristic length is d = 22 nm.
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ing with a calcium rise and in the amount of calcium taken up
by each cell, (Δ[Ca2+]i). The increase of the total intracellular
calcium concentration reached after the administration of
digested Ca–CPPs (tot [Ca2+]i) as compared to its undigested
counterpart is notably higher in Caco2 cells (778%) as com-
pared to HT-29 cells (192%), beyond the absolute values of the
single measures in the two cell lines. Reversely, in the case of
Ca–dekCPP, the digestion procedure depletes the overall
increase in calcium uptake (tot [Ca2+]i), through a reduction
either in the number of responsive cells or in the single-cell
calcium increase, depending on the cell type. In both cases, a
reduction to less than 80% in eﬀectiveness is observed (78% in
Caco2 cells and 72% in HT-29 cells) (Table 2 and 3).
4. Discussion
Bioactive peptides released by the gastrointestinal digestion of
food proteins can exert biological properties in addition to the
well-known nutritional ones, both soon after digestion, mainly
toward intestinal cells, and after their absorption by the intes-
tine, when they have reached their specific targets in the body.
Digestion and absorption are limiting steps for the bioavail-
ability of peptides; thus the in vitro digestion procedures com-
bined with the use of intestinal cell models allowed to mimic
the physiological milieu, where digestion occurs, and the inter-
actions between peptides and intestine, the latter representing
the first contact between food and our body.41
The potentiality of the casein phosphopeptides has been
evidenced in recent publications.10,11 In this context, the
present paper addresses the modifications occurring in the
structure of (CPP + calcium) aggregates at the various digestion
steps (in vitro procedure), concerning their complexation with
calcium ions, in relation to the eﬀect on their ability to induce
calcium uptake by intestinal cells, without any concern about
the peptide transport, which is outside the scope of the
present study.
The in vitro digestion of CPPs gives rise to a mixture of pep-
tides from beta and alpha s1 casein, mostly composed of 5–15
amino acids, with one or more phosphoserines. Moreover, the
fragment 41–70 from alpha s1 casein contains the phosphory-
lated acidic motif SSSEE. Although showing increased frag-
mentation with respect to the undigested CCPs, this peptide
pattern is consistent with the ability to bind calcium ions, the
property specifically addressed here. In this sense, the first
aspect to be evaluated was the persistence of the CPP aggre-
gates with calcium ions even after digestion, since this is fun-
damental to promote any calcium uptake by the cells.24
Fig. 5 Eﬀect of CPPs in Caco2 cells. The average change in cytosolic calcium, [Ca2+]i, after administration (1280 µM) of Ca–CPPs (A), digested Ca–
CPPs (B), Ca–dekCPPs (C) and digested Ca–dekCPPs (D) together with relative SD is shown. Each graph represents the average behaviour of 10–12
independent experiments, each of them consisting of a minimum of 40–60 analysed cells.
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As far as the structure of (CPP + calcium) aggregates is con-
cerned, two levels have been identified: a large-scale structure,
some hundreds of nm in size (the peptide matrix), and a small
substructure, more ramified, with fractal or entangled chain-
like conformation typical of polycondensates. Although appar-
ently similar, this internal structure is quite diﬀerent from
that found for whole-casein, the parent protein, that arranges
as a network with reticulated amorphous calcium–phosphate
nanoclusters,42 modelled as oblate ellipsoids.43 We underline
that in the CPP solutions used here, the phosphate groups are
Table 2 Statistical analysis of Ca–CPP and Ca–dekCPP eﬀects on
calcium uptake in Caco2 cells before and after the simulated digestion
processa
Treatments
% Responsive
cells
Δ[Ca2+]i
(nM)
tot [Ca2+]i
(nM)
Ca–CPPs 15 27 ± 9 405
Digested Ca–CPPs 70° 45 ± 10* 3150
Ca–dekCPPs 26° 40 ± 20* 1040
Digested Ca–dekCPPs 18^$ 45 ± 13* 810
a The statistical significance for cell responsiveness (% responsive
cells) was assessed using the χ2 test: significantly diﬀerent from Ca–
CPP (°, p < 0.005); from digested Ca–CPP (^, p < 0.005); from Ca–
dekCPPs ($, p < 0.005). The variations in the average single-cell
intracellular calcium concentration (Δ[Ca2+]i) were analyzed by
Student’s t-test (*significantly diﬀerent from Ca–CPPs, p < 0.01). Each
value represents the mean ± SD of 10–12 analogous experiments for at
least 400 analyzed cells. Details of the calculations are reported in the
Materials and methods section.
Fig. 6 Eﬀect of CPPs in HT-29 cells. The average change in cytosolic calcium, [Ca2+]i, after administration (1280 µM) of Ca–CPPs (A), digested Ca–
CPPs (B), Ca–dekCPP CPPs (C) and digested Ca–dekCPPs (D) together with relative SD is shown. Each graph represents the average behaviour of
10–12 independent experiments, each of them consisting of a minimum of 70–90 analysed cells.
Table 3 Statistical analysis of Ca–CPP and Ca–dekCPP eﬀects on
calcium uptake in HT-29 cells before and after the simulated digestion
processa
Treatments
% Responsive
cells
Δ[Ca2+]i
(nM)
tot [Ca2+]i
(nM)
Ca–CPPs 70 76 ± 28 5320
Digested Ca–CPPs 89° 115 ± 19* 10 235
Ca–dekCPPs 93° 113 ± 59 10 509
Digested Ca–dekCPPs 96°^ 79 ± 14# 7584
a The statistical significance for cell responsiveness (% responsive
cells) was assessed using the χ2 test: significantly diﬀerent from Ca–
CPPs (°, p < 0.005); from digested Ca–CPPs (^, p < 0.005). The
variations in the average single-cell intracellular calcium concentration
(Δ[Ca2+]i) were analyzed by Student’s t-test (*significantly diﬀerent
from Ca–CPPs, p < 0.01); from digested Ca–CPPs (#, p < 0.01). Each
value represents the mean ± SD of 6–8 analogous experiments for at
least 500 analyzed cells. Details of the calculations are reported in the
Materials and methods section.
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just those belonging to the phosphorylated serines of CPPs,
thus in equimolar ratio with serine residues, see the Materials
and methods section. No additional phosphate ions are
present. Moreover, CPP chains are shorter than those of
casein, and the fraction of serine residues in Ca–CPP is higher
than that for casein (10.3% vs. 6.1% w/w).24 Aggregation does
not take place in the absence of Ca ions9 and supramolecular
organization of the CPP chains is promoted by divalent
calcium ions, coordinating diﬀerent phosphoserine residues
belonging to the same or to diﬀerent chains.
As expected, and as observed also in casein micelles at
varying pH,44 digestion modifies the CPP aggregates on both
overall and local scales. On the large scale, CPP aggregates
reduce in size upon digestion, but are still present. Peptides
are fragments of casein, and their ability to form aggregates
seems to be preserved, more than for casein. At pH 2, simulat-
ing the gastric step, the charges on the peptide chains, includ-
ing those of the phosphoserine residues, are neutralized, as in
casein. Charge interaction with calcium ions is lost. The size
distribution of aggregates shifts towards small structures (a
few tens of nm) that correspond to oligomers, possibly stabil-
ized also by hydrophobic interactions. As the pH is raised,
simulating the following intestinal step, large aggregates
quickly reform, since the condensation nuclei are still present.
In fact, on the local scale an entangled substructure is pre-
served throughout the process of digestion, as inferred from
X-ray results (Fig. 3). The eﬀect of acidification and enzyme
action on this internal substructure of the aggregates shows
up as a decrease in the radius of gyration of the subchains,
connected to the characteristic distance between calcium com-
plexation sites. Those findings indicate that complexation sites
and the embedded calcium become more finely distributed in
the peptide matrix. This fully agrees with the mass spec-
trometry result, revealing an increased fragmentation of CPPs
upon in vitro digestion, moving the CPP distribution towards
shorter peptides, mostly carrying one or more phosphoserines.
Then, they preserve their ability to bind calcium in a mesh of
smaller size.
From the structural point of view, then, digestion preserves
the presence of supramolecular complexes, their size being
still suitable to promote calcium internalization by intestinal
cells. Moreover, digestion renders CPP aggregates more homo-
geneous-inside, dispersing condensation sites and disordering
the network structure.
From the biological point of view we separately discussed
results obtained using Ca–CPPs or Ca–dekCPPs in our cell
intestinal human models.
Caco2 and HT-29 cells share the same origin from human
colon adenocarcinoma, but, when diﬀerentiated, they acquire
new features as described in detail,45 such as the brush border
associated hydrolases and structures which make them more
similar to the cells of the small intestine. Nonetheless, some
diﬀerences are still present. First of all, in strict connection to
the tumoral origin of these cells, they display a high glucose
consumption rate and glycogen accumulation. Second, the
lack of lactase in HT-29 cells and of maltase-glucoamylase in
both cell types make them diﬀerent from the colon, where
hydrolases are not present, but also from the small intestine.
Still, due to the diﬃculties encountered in using in vitro
primary cultures of bioptic intestinal fragments, HT-29 and
Caco2 are considered suitable models and are the most used
cell lines for studies of drug transport and/or cell toxicity.
Known diﬀerences in the morphology and function of the two
cell populations are present, depending on the cell culture and
diﬀerentiation protocol, which permits to choose one cell line
rather than the other, based on the research target.
In this regard, diﬀerentiated Caco2 cells, which constitute a
monolayer of mainly absorptive epithelium, resemble the duo-
denum cells,45 where the percentage of goblet cells reaches
only 10%, as supported by a higher sucrase–isomaltase
activity as compared to HT-29 cells.9,31,46 Besides, they show
that, by a higher presence of digestive enzymes47 as it
appears for the duodenum, the intestinal tract is more
involved in the digestion of food. Even the presence of
transporters like the TRPV6 channel,12 indicative of the trans-
cellular calcium absorption as the main pathway, as it was
observed in duodenum,48 together with the absence of L-type
calcium channels, more typical of jejunum and ileum,
where calcium is absorbed via a paracellular route, indicates
that Caco2 cells are reasonable representatives of duodenum
like cells.48
HT-29 cells, instead, present features of a more hetero-
geneous population with a minor proportion of the absorptive
phenotype, together with a minor level of digestive enzymes.47
These cells are characterized also by the presence of L-type
calcium channels11 and by a major permeability of their junc-
tions, all signs of a higher level of absorption processes charac-
teristic of the jejunum and ileum tracts.
Despite the limitations associated with the use of the
described cell lines as a model of the human intestine, they
have been preferred in place of other methods. In fact, a
diﬀerent possibility to study the CPP eﬃcacy on calcium
uptake by the intestine could be the Ussing Chamber, which is
useful to monitor a passage of substance. In this sense, pre-
liminary experiments have used the everted distal small intes-
tine of rats demonstrating a positive eﬀect exerted by CPPs in
dependence of the CPP/calcium ratio.49 The choice to use both
cell lines lies in the possibility to distinguish between the two
diﬀerent principal mechanisms for calcium uptake activated
by CPPs as demonstrated in previous studies.11,12
4.1. Ca–CPPs
The first important result is that digestion of Ca–CPP aggre-
gates leads to an increased uptake of calcium ions in intestinal
cells, both Caco2 and HT-29, with an impressive eight-fold
improvement in Caco2 cells. Improved bioactivity may be due
to the modulation of the interaction between Ca–CPP aggre-
gates and the cell surface, for instance the type and duration
of contact between aggregates and cells; besides, solubility
may improve calcium availability. The increased bioavailabil-
ity, after digestion, of the calcium associated with Ca–CPPs is
evident, as both types of cells display an increase in calcium
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uptake, a feature dependent both on the mechanism of inter-
action with cells and on the amount or the distribution of
calcium within the complexes. Optimized dispersion of
calcium within digested Ca–CPPs, as revealed by SAXS, can
predispose for a higher solubility, and thus availability, of the
mineral. Concerning the complicated interaction between the
aggregates and the cell membrane, it may reasonably depend
on the structural properties of the Ca–CPP complexes. Again, a
plausible softening of digested Ca–CPP complexes, displaying
a less rigid conformation with respect to the undigested ones,
as revealed by SAXS, may promote better interaction with the
cell membrane surface.
Comparison between the two cell lines, Caco2 and HT-29,
can give some hint.
Both cell lines give a better response to digested Ca–CPPs
with respect to the undigested complexes, but the huge
enhancement (eight times more) induced in Caco2 cells, to be
compared with the two-fold enhancement induced in HT-29
cells, is the most astonishing result. Let us then consider the
two main mechanisms through which CPPs trigger the uptake
of calcium: mainly via the TRPV6 channel, thus transcellular,
regulated by vitamin D, in Caco 2 cells,12 and via the depolar-
izing L-type calcium channels, thus paracellular, not vitamin
D regulated, in HT-29 cells.10 In vivo, transcellular calcium
absorption takes place in the duodenum, according to a satur-
able kinetics, when the extracellular calcium concentration is
low. Reversely, paracellular calcium absorption takes place in
the distal jejunum and ileum when the extracellular calcium
concentration is very high, for instance after a meal.48
In the case of Caco2 cells, morphologically and functionally
very similar to the duodenum cells,12 the huge enhancement
in calcium uptake when treated with the digested Ca–CPP
complexes as compared to the undigested homologues is
mainly due to the ∼5-fold increase in the fraction of respond-
ing cells, each one roughly doubling the amount of interna-
lized calcium (see Table 2). It can be hypothesized that Ca–
CPP rearrangement following digestion increases the amount
of finely dispersed, slowly supplied, complexed calcium (thus
improving the single-cell calcium uptake), meanwhile reducing
the amount of free calcium responsible of the downregulation
of TRPV6,11 thus raising the number of responding cells.
In the case of HT-29 cells, very similar to the jejunum and
ileum cells,11 the percentage of responsive cells to Ca–CPPs is
very high, already in the presence of the undigested form. This
is expected for a mechanism devoted to massive calcium recov-
ery, in abundance of calcium, both CPP-bound and free in
solution. Digestion, reasonably, mainly aﬀects the amount of
calcium taken up by single cells, rather than the already huge
number of responsive cells (see Table 3). Again, an increase in
the fraction of complexed calcium (the most bioactive form)
can be at the basis of the uptake eﬃciency improvement.
4.2. Ca–dekCPPs
Diﬀerently from Ca–CPPs, Ca–dekCPPs are very sensitive to the
extracellular calcium concentrations, as they recruit all of the
available calcium ions, while forming the bioactive aggre-
gates.24 As compared to Ca–CPPs, Ca–dekCPPs, with a less
defined internal structure, display a higher capacity for pro-
moting calcium uptake in both types of cells, in the undi-
gested form. In Caco2 cells, this could be due to the
eﬀectiveness of dekCPPs in subtracting free calcium ions from
the extracellular space, with a smaller downregulation of the
TRPV6 channel. In HT-29 cells, more calcium bound to bio-
active dekCPP aggregates, as compared to the Ca–CPPs, is
reflected in higher calcium uptake. Interestingly, and opposite
to Ca–CPPs, digestion reduces this ability. The instability of
the Ca–dekCPP complexes is likely to be at the basis of their
reduced performance. In Caco2 cells the responsiveness
decreases to a value similar to that observed when undigested
Ca–CPPs are administered, probably for an increased downre-
gulation of the TRPV6 channel due to a higher amount of
calcium ions freed from a labile Ca–dekCPP matrix. Accord-
ingly, in HT-29 cells, the reduction in calcium uptake indicates
a lowering in the calcium content of the most bioactive CPP
complexes. The modification of the CPP complexes operated
by digestion and its eﬀect on the interaction with the cell
membranes are also evident from the enhanced heterogeneity
in the time course profiles of the intracellular calcium concen-
tration in digested dekCPPs.
The CPP mixture we addressed in the present and previous
studies is a preparation purified from bovine casein.
The formation of CPPs from casein digestion is an issue
much addressed in many studies. It has been shown to occur
in vitro, from the digestion of skim milk16 and/or from milk
based infant formula digestion4 or from milk fruit beverages,50
and also, most importantly, in vivo with the detection of CPPs
in human plasma following digestion of milk and yogurt6 as
well as in the distal ileostomy fluid.51 Nonetheless, the possi-
bility that, after a dairy meal, aggregates of CPPs and calcium
can be formed at the optimal conformation and molar ratio,
such as the ones described above, and therefore bioactive after
the modification induced by the digestion, and high-perform-
ing, is a desirable issue, but unfortunately unrealistic. In fact,
two main aspects have to be considered: (a) the probability
that biologically active casein phosphopeptides do originate
and in appreciable amounts after digestion, (b) diﬀerent food
matrix and physiological conditions, such as digestion
eﬃciency, can produce every time diﬀerent types of peptides.
In addition, in vitro digestion does not result in the same exact
peptides as in vivo digestion, since factors like food matrix,
environmental conditions, and physiological alteration, can
modulate the eﬃciency and thus the product of digestion.
Besides, the digestion of dairy products by infants, due to the
incomplete pool of proteases of their immature gastrointesti-
nal apparatus,52 can originate peptides with diﬀerent struc-
tures and bioactivity as compared to adults.
An optimized formulation for extra calcium supply with
easy delivery could then be employed for those segments of
population, as children or seniors, with a higher demand for
the mineral, or in the presence of pathological conditions
such as osteoporosis.
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5. Conclusion
Data presented here demonstrate for the first time that after
digestion pre-formed (CPP + Ca) aggregates still maintain their
conformation and retain their bioactivity as promoters of
calcium uptake in intestinal cells. The employment of purified
CPPs pre-complexed with calcium ions proved to be funda-
mental, as it prevents problems occurring when casein hydro-
lysis results in uncontrolled mixtures of CPPs. Besides, this
choice is instrumental to bioactivity, due to the bioavailability
of the mineral and the stability of aggregates. Apart from
numerical values, always digestion of complexes has proved to
enhance calcium uptake, whatever their mechanism of inter-
action with plasma membranes, TRPV6 in Caco2 cells and
depolarizing L-type calcium channels in HT-29 cells. Thus, a
CPP formulation with the features described here, adminis-
tered as dietary supplements, stands as a promising tool for
calcium delivery. Its eﬃciency is likely to be higher than when
incorporated in the form of ingredients into traditional and/or
novel foods, the release from food matrix and the digestion
survival being possible limiting factors. Meanwhile the ease of
administration is kept. In conclusion, results presented here
strengthen the possibility of considering CPP-based calcium
vectors as nutraceuticals or supplements to be employed in
every situation requiring high calcium absorption.
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